ArticleImmunologic research2025
Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in lung adenocarcinoma.
Bing Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it